Class | CCY | SZE(M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | GDNC | SPRD | CPN | YLD | PRICE |
---|
A | USD | 202.000 | 4.60 | Aaa | - | - | - | - | 37.00% | - | Floating | 3mL | - | 195 | 3mL+195 | - | - |
A-L | USD | 50.000 | 4.60 | Aaa | - | - | - | - | 37.00% | - | Floating | 3mL | - | 195 | 3mL+195 | - | - |
B | USD | 51.600 | 6.40 | - | - | AA | - | - | 24.10% | - | Floating | 3mL | - | 265 | 3mL+265 | - | - |
C-1 | USD | 19.400 | 6.80 | - | - | A+ | - | - | 19.25% | - | Floating | 3mL | - | 317 | 3mL+317 | - | - |
C-2 | USD | 3.400 | 7.00 | - | - | A | - | - | 18.40% | - | Floating | 3mL | - | 405 | 3mL+405 | - | - |
D | USD | 23.600 | 7.40 | - | - | BBB- | - | - | 12.50% | - | Floating | 3mL | - | 425 | 3mL+425 | - | - |
E | USD | 14.800 | 7.90 | - | - | BB- | - | - | 8.80% | - | Floating | 3mL | - | 800 | 3mL+781 | - | - |
F | USD | 1.000 | 8.20 | B3 | - | - | - | - | 8.55% | - | - | - | - | - | - | - | Retained |
Eq | USD | 32.200 | - | NR | - | NR | - | - | - | - | - | - | - | - | - | - | Retained |
Tranche Comments
D: First Pay: 2023-01-20; Redemption: 2023-07-27; Registration: 144A/Reg S;
C-1: First Pay: 2023-01-20; Redemption: 2023-07-27; Registration: 144A/Reg S;
C-2: First Pay: 2023-01-20; Redemption: 2023-07-27; Registration: 144A/Reg S;
B: First Pay: 2023-01-20; Redemption: 2023-07-27; Registration: 144A/Reg S;
F: First Pay: 2023-01-20; Redemption: 2023-07-27; Registration: 144A/Reg S;
A: First Pay: 2023-01-20; Redemption: 2023-07-27; Registration: 144A/Reg S;
E: First Pay: 2023-01-20; Redemption: 2023-07-27; Registration: 144A/Reg S;
A-L: First Pay: 2023-01-20; Redemption: 2023-07-27; Registration: 144A/Reg S;
Eq: First Pay: 2023-01-20; Redemption: 2023-07-27; Registration: 144A/Reg S;
Deal Comments
Non Call Period: 1.00
Reinvestment Period (YRS)
3
Reinvestment Period End Date
Jul 20, 2025
AllReportsSurveillanceOther
Sector | Name | Type | Publisher | Date |
---|
CLOS | Carlyle US CLO 2022-3: Short-dated new issue has broad-scope restricted trading period | Scorecard | Dealscribe | Sep 21, 2022
|